Skip to content

Effects of AD on VI in Patients With CF

Effects of Autogenic Drainage on Ventilation Inhomogeneity in Patients With Cystic Fibrosis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03655249
Enrollment
30
Registered
2018-08-31
Start date
2018-08-01
Completion date
2025-12-31
Last updated
2024-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis

Keywords

Multiple breath washout, Electrical impedance tomography, Lung clearance index, Chest physiotherapy, Autogenic drainage, Cystic fibrosis

Brief summary

This study will investigate the effects of a chest physiotherapy manual technique (autogenic drainage) on ventilation inhomogeneity in patients with cystic fibrosis. Lung clearance index (LCI) is the primary outcome

Detailed description

This is a cross-over intervention assessing the effect of autogenic drainage on ventilation inhomogeneity in patients with cystic fibrosis. Electrical impedance tomography and multiple breath nitrogen washout will be performed before, immediatly after and 2h post intervention. Each participant will receive either aerosoltherapy alone or in combination with chest physiotherapy on 2 consecutive days.

Interventions

Autogenic drainage is an airway clearance technique that attempts to obtain the optimal airflow to evacuate the secretions. This technique uses modulation of inspiratory and expiratory airflow at different breathing level within the vital capacity.

DRUGAerosoltherapy

Aerosolized drugs are individualized for each participants, in line with current standardized practice in our hospital. Those drugs will not be modified for the purpose of this study.

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants receive one of two interventions during the first day, and receive the alternative intervention the following day. Interventions are : aerosoltherapy + autogenic drainage or aerosoltherapy alone

Eligibility

Sex/Gender
ALL
Age
6 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Cystic fibrosis diagnosis * FEV1 \> 40% * Able to sustain 30min of chest physiotherapy

Exclusion criteria

* Presence of Burkoldheria cepacia or non tuberculous mycobacteria * Orthopedic, neuromuscular or cardiac disorder likely to impact respiratory system * Need for supplemental oxygen * Cardiac pacemaker or internal cardiac defibrillator

Design outcomes

Primary

MeasureTime frameDescription
Change in Lung Clearance IndexUp to 2 weeksLCI will be measured before, immediately after and 2h after the experimental or control conditions as well as before and after an hospitalization.

Secondary

MeasureTime frameDescription
Impedance variationUp to 1 hourImpedance change in different lung zones

Countries

Belgium

Contacts

Primary ContactWilliam Poncin, PT, PhD
william.poncin@uclouvain.be+3227642316
Backup ContactGregory Reychler, PT, PhD
gregory.reychler@uclouvain.be+3227642316

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026